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Fabrication and Verification of 
Conjugated AuNP-Antibody 
Nanoprobe for Sensitivity 
Improvement in Electrochemical 
Biosensors
Patricia Khashayar1,2,3, Ghassem Amoabediny4,5, Bagher Larijani6, Morteza Hosseini1 & Jan 
Vanfleteren2
This study was designed to obtain covalently coupled conjugates as means for achieving higher stability 
and better coverage of the AuNPs by antibodies on the particle surface suitable for sensor performance 
enhancement. Starting by using a modified protocol, colloid gold solution, with mean AuNP core size 
of ~6 nm was synthesized. The protocol used for conjugation of AuNPs to osteocalcin antibody in this 
study relies on covalent and electrostatic attractions between constituents. Varieties of conjugates 
with varying combinations of crosslinkers and different concentrations were successfully synthesized. 
The obtained products were characterized and their properties were studied to determine the best 
candidate in sense of antibody - antigen reactivity. Using AuNP-GSH-NHS-Ab combination (1:1:1), the 
tertiary structure of the protein was maintained and thus the antibody remained functional in the future 
steps. This one-pot method provided a simple method for covalently coupling antibodies on the particle 
surface while keeping their functionality intact. The AuNP content of the solution also accelerated 
electron transfer rate and thus amplifies the detection signal. With the developed and discussed 
technique herein, a simple solution is modeled to be used for measuring serum levels of biomarkers in 
single and/or multiplexed sensor systems.
Designing sensors with higher efficiency depends on the development of novel materials to improve both the 
recognition and transduction steps. Studies have shown that labeling biomolecules with noble metal NPs results 
in highly sensitive and specific bioassays, while maintaining the bioactivity of the biomarker1–3. Such NPs can also 
help improve signal detection for low concentration of analytes.
Gold nanoparticles (AuNPs) are the most commonly used labels in sensor studies because of their intriguing 
size dependent electrical, optical, magnetic, and chemical properties as well as their ease of synthesis and surface 
functionalization4,5. Being redox active, AuNPs provide the possibility for miniaturizing the sensing devices to 
nanoscales, offering excellent prospects for chemical and biological sensing. They also provide a suitable platform 
for multifunctionalization with a wide range of organic or biological ligands for selective detection of biomarkers6.
As a result, broad potential of AuNPs for signal amplification in antibody (Ab) – antigen (Ag) reaction events 
on simple, ultrasensitive, multiplexed immunosensors become apparent7. AuNP conjugation with different pro-
teins is well studied in the literature but the mechanisms behind the process are poorly understood8–11. Therefore, 
special attention is needed to ensure the quality of the end product. Different protocols were thus tested in this 
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study to confer a controlled immobilization of antibody on the surface, while maintaining the activity of the 
bounded antibody. With the developed and discussed technique herein, a simple solution has been modeled to be 
used for measuring serum levels of biomarkers in single and/or multiplexed sensor systems12,13.
Results and Discussion
Characterization of AuNPs. The sodium citrate in the AuNP preparation procedure behaves as a reducing 
agent. It also provides the negative surface charge around the AuNPs, needed to repel the particles and restrain 
any aggregation. The concentration of gold salt and trisodium citrate as well as the temperature and mixing rate 
are main factors defining the size-distribution of the synthesized colloidal gold nanoparticles14.
In this work, TEM was used to characterize the morphology and determine the size of the as-prepared AuNP 
solution. According to the ImageJ results, uniformly distributed, mainly spherical, nanoparticles with an average size 
of 6.53 ± 1.8 nm were observed in the solution with very few particles of higher and lower size distribution (Fig. 1).
The mean hydrodynamic diameter of the nanoparticles, suggestive of the mean diameter of the majority of the 
particles according to number (%) was measured using a zeta-sizer nano-ZS (Fig. 2). As expected, the DLS values 
were larger than those reported by TEM (7.48 nm vs. 6.53 nm) due to the presence of the double layer effect in the 
calculations of the hydrodynamic radius of the particles in the solutions, and its absence in that of the dried-state 
samples imaged by TEM. Moreover, DLS results are quite dependent on the viscosity and temperature.
Assuming a spherical shape and a uniform FCC crystal structure, the average number of gold atoms per nan-
oparticle (N) was calculated using the following equation (eq. 1) and based on TEM findings:
Figure 1. TEM results. (a) Monodispersed gold nanoparticles, (b) Gold nanoparticles capped with GSH, (c) 
Antibody- conjugated gold nanoparticles (With permission)13.
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where D is the average core diameter of the particles (nm), ρ is the density for fcc gold (19.3 g/cm3), and M stands 
for the atomic weight of gold (197 g/mol)15.
Then the molar concentration of the nanosphere solution was calculated by dividing the total number of gold 
atoms (Ntotal = initial amount of gold salt added to the reaction solution) by the average number of gold atoms per 
nanosphere (N), using the following equation (eq. 2):
= = . ∗ −C N
NVN
mol L1 96 10 /
(2)
Total
A
6
The properties of the prepared AuNP solution were also determined through calculation of its extinction 
coefficient as well as the absorption peak and curve appearance. The UV–Vis spectrophotometer has been the 
first optical technique employed for this regard. In this method, the width of the absorption spectra is related to 
the size distribution range of the nanoparticles; as a result, the absorption peak shifts to longer wavelengths with 
Figure 2. DLS results. (a) Gold nanoparticles, (b) Gold nanoparticles capped with GSH, (c) Ab - conjugated 
gold nanoparticles (with Permission)13.
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increasing particle size. In the present study, the plasmon absorption peak was observed at ∼520 nm, which is 
corresponding to the typical surface plasmon resonance (SPR) of colloidal AuNPs prepared by the conventional 
citrate reduction method (Fig. 3)16. Lack of a band at around 680 nm indicated the absence of aggregated gold 
particles and thus confirmed the successful preparation of an AuNP solution17.
The Lambert-Beer law was used to calculate the extinction coefficient, the sum of absorption and scattering 
coefficients (ε), of the nanoparticle solution (eq. 3).
A bC M cm2 65 10 / (3)8ε ε= → = . ∗
Where A is the absorbance at 520 nm, b is the length of solution that the light passes through (cm) and C is the 
concentration of the solution (mol/cm3).
It should be noted that the calculated extinction coefficient of our colloid solution was higher than the solu-
tions made using the same technique in the literature (8.56 ∗ 106 or 5.14 ∗ 107)15.
AuNP/Ab nanocomplex. This study was designed to obtain covalently coupled conjugates as means for 
achieving higher stability and better coverage of the AuNPs by antibodies on the particle surface suitable for sen-
sor performance enhancement. GSH is a tripeptide biomolecule (–Glu-Cys-Gly), containing a –SH group which 
can easily be adsorbed onto the AuNP surface. A dense layer of GSH-AuNP enlarges the electroactive surface 
area and provides carboxylic groups for covalently binding of the particles to a dense layer of antibody/protein 
for detection. EDC and sulfo-NHS, on the other hand, acted as cross-linkers facilitating the bonding of an amine 
group of the antibody to the carboxylic group of GSH.
In other words, using this combination, the binding of antibody complex to gold atoms happened through 
thiol linkages as well as ionic interactions between the negatively charged gold surface and the positively charged 
terminals on the complex, along with interactions originating from absorption of hydrophobic groups on AuNPs 
(Fig. 4). This is while the conjugates developed through direct absorption of the antibody on the surface of the 
nano-colloid particles using non-covalent bonds, such as London–van der Waals force and hydrophobic interac-
tions, are reported not to be stable18,19.
Functionality of AuNP/Ab nanocomplex. As mentioned earlier, the final goal in the sensor devel-
opment process is to maintain the bioactivity and functionality of the antibody immobilized on the electrode 
surface. In this regard, various techniques are reported in the literature20–22. Our results revealed that using 
AuNP-GSH-NHS-Ab combination (1:1:1), the tertiary structure of the protein was maintained and thus the anti-
body remained functional in the future steps. This was confirmed based on a significant decrease noted in the 
maximum peak after the antigen was left to react with the electrode modified with the 1:1:1 GSH-NHS-Ab nano-
conjugate for at least 2 hours. The reason behind the noted decrease in the measured current is the fact that the 
binding of antigen to the immobilized antibody disrupts electron transfer.
As for the rest, a minimum change from baseline value (<3%) was reported, indicating that the antibody 
bounded using those protocols either had lost its activity or did not have the correct orientation (Fig. 5). In other 
words, the conjugates were found not to be functional in the presence of EDC; this could be explained by the fact 
that EDC may resemble hydroxyapatite effects and thus alter the tertiary structure of the osteocalcin23.
Another advantage of the abovementioned method was that covalent coupling via a cross-linker is specific and 
controllable. Thus, the nanocomplex prepared using this protocol is going to be discussed in the rest of this article.
Characterization of AuNP/Ab nanocomplex. Characterization of the resulting conjugates was done by 
TEM measurements of freshly prepared solution (Fig. 1). GSH molecules are believed to form certain intermo-
lecular hydrogen binding among themselves, even when they are adsorbed on AuNPs24. The concentration ratio 
of GSH and AuNP, thus, is one of the important factors that affects the aggregation rate in the solution. According 
to our results, no aggregates were formed upon the addition of GSH to the AuNP solution. UV-Vis confirmed the 
Figure 3. UV–Vis spectra of (a) colloidal AuNPs (b) GSH-capped AuNPs.
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successful formation of GSH-capped AuNPs; and the absence of any significant alteration in particle morphology 
or size, based on TEM and DLS findings, confirmed the latter (Figs 2 and 3).
The attachment of the antibody to GSH-modified gold nanoparticles, on the other hand, resulted in a con-
siderable increase in size and the formation of core-shell structure, which is in accordance with the findings of 
previous reports25,26. In other words, the size increase confirmed the existence of an additional layer of conjugated 
antibody on the nanoparticles.
Assuming that the increase in the particle size (diameter) was caused by the NHS-Ab, one could also conclude 
that this increase is equivalent to the diameter of the monolayer of antibody around the core AuNP. Thus, the 
volume of the core-shell is calculated as the difference between the antibody-conjugated nanoparticles and the 
AuNP, given by (eq. 4):
= . − = .V D d nm0 5236( ) 8333 53 (4)3 3 3
where D is the diameter of the antibody-conjugated nanoparticles and d is the diameter of the core AuNP. By 
dividing the volume of the core-shell by that of the antibody obtained using the calculated hydrodynamic diame-
ters, it could be concluded that at least 2 antibodies attach to each nanoparticle in this technique.
Figure 4. Representative schematic showing nanoconjugate formation steps.
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Figure 5. DPV plots of two different nanoconjugates before and after reaction with antigen (Ag) for 2 hrs.
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Nanoparticle colloid is stabilized by the electrostatic forces, indicated by the zeta potential of the particles in 
solution. This arises due to an energy barrier originating from the balance between two opposing forces: the van 
der Waals attractive (VA) and electrical double layer repulsive (VR) forces between the particles approaching each 
other27. This barrier prevents the two particles from agglomerating.
Zeta potential is influenced by the thickness of the electrical double layer, the electrical charge in this layer 
and dielectrical constant28. As a result, the particle’s surface charge is an important factor influencing the stability 
and reactivity of the nanoparticle, and thus can greatly enhance the nanoparticle conjugates’ application. In line 
with the Huckel’s theory, our results showed that the zeta potential value increased with particle size, and that the 
particle charge is directly proportional to the zeta potential.
Optimization of AuNP/Ab nanoconjugate. The preparation of a well-dispersed nanoprobe with uni-
form size distribution and no aggregation is of great importance in immunoassay studies. Therefore, lowest 
amount of antibody enough to stabilize the gold was determined by incubating 1 mL of colloid gold with anti-
body solutions at varying concentrations (1–50 ug/mL, 1 mL) for 5 min. Thereafter, 0.5 mL of 10 % (w/v) NaCl was 
added and the color of the solution was noted. The concentration in which the color of the solution turned blue 
was considered as the minimum required amount for stabilization.
Further tests to assess the reactivity of the nanocomplex towards antigen showed that lower concentrations of 
antibody produced small current change, suggestive of the absence of sufficient amount of antibody to react with 
the antigen on the surface. Higher concentrations of the nanoprobe, on the other hand, improved the current 
while contributing to higher nonspecific adsorption.
As mentioned in the literature, environmental factors such as temperature and pH play an important role in 
the efficiency of the nanoconjugate29,30. Thermal optimum depends on the chemical nature of the protein, adding 
that hydrogen bonds are more stable at low temperature, whereas the strength of the hydrophobic bonds increases 
with temperature31. Antigen - antibody reactions are also expected to stabilize at lower temperatures. According 
to our results, however, no significant change was reported when the incubation was performed at a temperature 
range of 4 °C to room temperature. As a result, to simplify the process, all the processes were performed at room 
temperature and the optimized incubation time for this temperature, needed for saturated binding of the immu-
noreaction, was calculated to be 2.5 hours.
The pH of the solution is another factor affecting the quality of the end product. The optimal reaction rate of 
NHS chemistry proceeds around pH 4.5–7.2. In other words, NHS-esters hydrolyze faster in higher pH, whereas 
no reaction takes place at pH values lower than 3.532. As for GSH, best results are achieved by adjusting the pH at 
values in which the carboxylic groups are in their protonated form. This occurs when GSH is as a zwitterion (pH = 
3–7)33. Moreover, extreme pH values induce marked conformational changes in the Ab molecule that probably 
may affect its complementarity with the antigen. On the other hand, since osteocalcin, the Ab used in this study, 
has an isoelectric point (pI) of 4.4, at lower pH values it carries more positive charge and thus positively influences 
the electrostatic attraction between the oppositely charged surface carboxyl anions and the protonated amino 
group of the ligand. As a result, no attempts were made to change the negative pH of the sulfo-NHS solution.
Conclusion
Generally, electrochemical sensors have the virtue of high sensitivity and selectivity, but they require several 
fabrication steps. Through the inherent interaction between AuNPs and antibody biomolecules, a novel gold nan-
oprobe was developed herein to be used in nonenzymatic electrochemical immunoassays. This one-pot method 
provides a simple method for covalently coupling antibodies on the particle surface while keeping their func-
tionality intact. The AuNP content of the solution also accelerates electron transfer rate and thus amplifies the 
detection signal.
The nanoprobe properties depend on particle size, combination and concentration of cross-linker and the 
Ab on one hand and the immobilization technique on the electrode on the other hand. The main idea of this 
study was to optimize the nanoconjugate to have an immunologically reactive solution toward the antigen. The 
next step, thus, would be to optimize the immobilization process of the nanoprobe on the electrode surface. 
Considering the results, the proposed method shows a promising potential for clinical applications.
Methods
Materials and reagents. Osteocalcin monoclonal antibody (ab13418) and full-length osteocalcin protein 
(ab152231) were purchased from Abcam Co. (UK) and were reconstituted in phosphate buffered saline (PBS). 
The latter was purchased in powder form from Sigma-Aldrich Chemical Co. (Belgium) and was used to prepare 
a working solution of 10 mM phosphate buffer (NaCl 0.138M, KCl 0.0027M), pH 7.4 at 25 °C. Tetrachloroauric 
acid (HAuCl4·3H2O), sulfo-a-N-hydroxysuccinimide (sulfo-NHS), b-1-ethyl-3-(3-dimethylamonipropyl) carbo-
diimide (EDC), L-Glutathione reduced (GSH), Bovine Serum Albumins (BSA), Potassium hexacyanoferrate (III) 
(K3Fe(CN)6) and trisodium citrate were also obtained from Sigma-Aldrich. Distilled water was used throughout 
the experiments.
Carbon (DRP-110) screenprinted electrodes (SPEs) (DRP-C223AT) were purchased from Dropsens (Spain).
Apparatus. In order to obtain information about structure, morphology and size of the synthesized AuNPs 
and antibody conjugated AuNPs, UV-Vis spectroscopy, transmission electron microscopy (TEM) analysis, 
dynamic light scattering (DLS) and zeta potential measurements were applied.
The absorption spectroscopic measurements were recorded using a UV Visible Spectrophotometer SPECORD 
250 (Analytik Jena, Japan).
The TEM images were obtained with an EM10C 80 KV (Zeiss, Germany) transmission electron micro-
scope. The samples for TEM measurements were prepared by placing a droplet of the colloidal solution onto a 
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carbon-coated copper grid and allowed it to dry in air. Using ImageJ software, the average core diameter of the 
particles were measured.
DLS measurements to determine the size of the particles were carried out using a MALVERN Instrument 
MAL1001767 UK, at the temperature of 25 °C and pH 7.4. By this method, the dynamics of the particles system in 
relation with the Brownian motion and fluctuations of scattered light was investigated with time. The frequency 
shifts, the angular distribution, the polarization, and the intensity of the scatter light were determined by the size, 
shape and molecular interactions in the scattering material. The Malvern Zetasizer Nano Instrument was also 
used for all zeta potential measurements.
All electrochemical experiments were performed using a computer-controlled DropSens STAT 400 (DropSens, 
Spain). They were carried out in a beaker, at room temperature (23 °C), using the three-electrode configuration. 
Differential Pulse Voltammetry (DPV) was performed to confirm surface modification changes. The DPV cycles 
were performed in 0.1 mM K3[Fe(CN)6], containing 0.01 M NaCl solution, applying following parameters: 0.05 V 
modulation amplitude, 0.01 s modulation time, 0.01 V step potential and voltage range from −0.5 to 0.5 V.
Synthesis of conjugated AuNP - antibody nanoprobe. — Synthesis of AuNPs. In order to synthesize 
10–100 nm AuNPs, the Turkevich method improved by Frens was used34,35. Briefly, 200 ml of 0.01 % HAuCl4 
solution was brought to boil while stirring gently. Thereafter, 4.5 ml of 1 % trisodium citrate was rapidly added 
to the boiling solution while stirring constantly for an additional 15 min. Once mixing occurred, the color of the 
solution changed gradually from light yellow to wine red. The solution was then cooled down to room tempera-
ture. This solution was stored at 4 °C for further use.
Synthesis of GSH-capped AuNPs. A stock solution of glutathione (10 mM) was prepared. Dilute HCl solution (10 
mM, 100 mL) was added to colloidal AuNP solution (3 mL) to lower the pH (~4)36. An aliquot of GSH solution 
(10 mM, 30 mL) was added to the acidic gold solution. This was the maximum amount required before the color 
of the solution changed from deep red to blue, indicating formation of aggregates amongst AuNPs.
Synthesis of AuNP - antibody Conjugates. A design of experiments (DOE) was prepared to assess the role of var-
ious parameters (different crosslinker combinations and concentration ratios) in manufacturing the AuNP - Ab 
conjugates, which would result in the best performance for the nanoprobe. The four parameters studied were the 
EDC (0, 100 mM, 200 mM, and 400 mM), sulfo-NHS (0, 100 mM, 200 mM and 400 mM), GSH (0, 10 mM) and 
Ab concentrations (10 µg/mL and 20 µg/mL). In other words, different concentration ratios of these material were 
combined to fabricate the nanoconjugate.
In each protocol, specific concentrations of the freshly prepared EDC and sulfo-NHS solutions were mixed 
and left to react for half an hour. Then the Osteocalcin antibody was added to the solution and incubated for 2.5 
hours. The complex was finally added to the GSH-capped AuNP solution and left to react for another hour. After 
each step, the solution was mixed using a fixed-speed vortex mixer. All the above mentioned procedures, mixing 
and incubating, was done at room temperature.
Functionality of AuNP/Ab nanocomplex. The reactivity of the AuNP/Ab nanoconjugates prepared using 
different protocols was tested using osteocalcin protein, herein referred to as the antigen (Ag). This was done by 
dropping 3 µL of the AuNP/Ab nanoconjugates on a gold SPE and waiting for an hour to dry. 20 µl of 0.2% BSA 
solution in PBS buffer was added to block the unreacted active functional groups. The electrode was then rinsed 
for 3 min with 0.1 M PBS to eliminate non-specific bindings. The baseline DPV plots were then recorded in 0.1 
mM K3[Fe(CN)6] for each nanoconjugate.
Thereafter 3 µL of the Osteocalcin antigen was dropped on the modified electrodes and left to react for 0.5, 1, 
2, 5, 10 and 20 hours. The second DPVs were then plotted.
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